Substance Use Disorders

  • Justine W. Welsh
  • Yujia Shentu
  • J. Wesley BoydEmail author
Part of the Integrating Psychiatry and Primary Care book series (IPPC)


Workforce substance use is a broad concept that encompasses substance use by employed individuals both inside and outside of the workplace. Workplace substance use involves the consumption of substances during the workday and can also include using substances outside of the workplace in a manner that adversely affects one’s ability to perform one’s work duties. Workplace substance use is often associated with decreased work attendance and lower job performance, costing the US economy billions of dollars each year. To offset these costs, companies have looked toward ways in which to promote healthy lifestyle choices and to provide options for early substance use interventions for their employees. In response, employee assistance and workplace wellness programs have been growing in popularity. However, more research is needed to understand their impact on substance-related outcomes. The workplace can also become a setting for substance use related interventions and referral to specialized treatment services. This chapter explores substance use in the workplace, including the adverse consequences of workplace substance use and how company policy and health programs have the potential to reduce its negative impact.


Workplace Workforce Substance use disorder Addiction Illicit drugs Alcohol Employee assistance programs Workplace wellness programs Physician health programs 


  1. 1.
    Substance Abuse and Mental Health Services. Results from the 2016 National Survey on Drug Use and Health: detailed tables [Internet]. Substance Abuse and Mental Health Services; 2017. Available from:
  2. 2.
    Substance Abuse and Mental Health Services Administration. The NSDUH Report: workplace policies and programs concerning alcohol and drug use [Internet]. 2014 [cited 2017 Oct 13]. Available from:
  3. 3.
    United States Department of Justice. The economic impact of illicit drug use on American society. Washington, DC: National Drug Intelligence Center; 2011.Google Scholar
  4. 4.
    Spicer RS, Miller TR, Smith GS. Worker substance use, workplace problems and the risk of occupational injury: a matched case-control study. J Stud Alcohol. 2003;64(4):570–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Frone MR. Prevalence and distribution of illicit drug use in the workforce and in the workplace: findings and implications from a U.S. National survey. J Appl Psychol. 2006;91(4):856–69.PubMedCrossRefGoogle Scholar
  6. 6.
    Frone MR. Workplace substance use climate: prevalence and distribution in the U.S. workforce. J Subst Use. 2012;71(1):72–83.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 National and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Kotov R, Gamez W, Schmidt F, Watson D. Linking “big” personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol Bull. 2010;136(5):768–821.PubMedCrossRefGoogle Scholar
  9. 9.
    Moore RS, Ames GM, Cunradi CB, Duke MR. Alcohol policy comprehension, compliance and consequences among young adult restaurant workers. J Workplace Behav Health. 2012;27(3):181–95.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Frone MR, Trinidad JR. Perceived physical availability of alcohol at work and workplace alcohol use and impairment: testing a structural model. Psychol Addict Behav. 2014;28(4):1271–7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Frone MR. Are work stressors related to employee substance use? The importance of temporal context assessments of alcohol and illicit drug use. J Appl Psychol. 2008;93(1):199–206.PubMedCrossRefGoogle Scholar
  12. 12.
    Frone MR. Relations of negative and positive work experiences to employee alcohol use: testing the intervening role of negative and positive work rumination. J Occup Health Psychol. 2015;20(2):148–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Frone MR, Trinidad JR. Relation of supervisor social control to employee substance use: considering the dimensionality of social control, temporal context of substance use, and substance legality. J Stud Alcohol Drugs. 2012;73(2):303–10.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Bush DM, Lipari RN. Substance use and substance use disorder by industry. In: The CBHSQ Report [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013 [cited 2017 Nov 14]. Available from:
  15. 15.
    Zhu J, Tews MJ, Stafford K, George RT. Alcohol and illicit substance use in the food service industry: assessing self-selection and job-related risk factors. J Hosp Tour Res. 2011;35(1):45–63.CrossRefGoogle Scholar
  16. 16.
    Frone MR. Alcohol and illicit drug use in the workforce and workplace [Internet]. Washington, DC: American Psychological Association; 2012 [cited 2017 Nov 14]. 269 p. Available from: CrossRefGoogle Scholar
  17. 17.
    Roche AM, Pidd K, Bywood P, Freeman T. Methamphetamine use among Australian workers and its implications for prevention. Drug Alcohol Rev. 2008;27(3):334–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Foster WH, Vaughan RD. Absenteeism and business costs: does substance abuse matter? J Subst Abus Treat. 2005;28(1):27–33.CrossRefGoogle Scholar
  19. 19.
    Howland J, Rohsenow DJ, Cote J, Siegel M, Mangione TW. Effects of low-dose alcohol exposure on simulated merchant ship handling power plant operation by maritime cadets. Addiction. 2000;95(5):719–26.PubMedCrossRefGoogle Scholar
  20. 20.
    Bazargan-Hejazi S, Gaines T, Duan N, Cherpitel CJ. Correlates of injury among ED visits: effects of alcohol, risk perception, impulsivity, and sensation seeking behaviors. Am J Drug Alcohol Abuse. 2007;33(1):101–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Quest Diagnostics. Quest Diagnostics Drug Testing Index: Full year 2016 tables. Secaucus, NJ: Quest Diagnostics; 2016.Google Scholar
  22. 22.
    Mangione TW, Howland J, Amick B, Cote J, Lee M, Bell N, et al. Employee drinking practices and work performance. J Stud Alcohol. 1999;60(2):261–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Bacharach SB, Bamberger P, Biron M. Alcohol consumption and workplace absenteeism: the moderating effect of social support. J Appl Psychol. 2010;95(2):334–48.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Streufert S, Pogash R, Roache J, Severs W, Gingrich D, Landis R, et al. Alcohol and managerial performance. J Stud Alcohol. 1994;55(2):230–8.PubMedCrossRefGoogle Scholar
  25. 25.
    McFarlin SK, Fals-Stewart W, Major DA, Justice EM. Alcohol use and workplace aggression: an examination of perpetration and victimization. J Subst Abus. 2001;13(3):303–21.CrossRefGoogle Scholar
  26. 26.
    Bacharach SB, Bamberger PA, McKinney VM. Harassing under the influence: the prevalence of male heavy drinking, the embeddedness of permissive workplace drinking norms, and the gender harassment of female coworkers. J Occup Health Psychol. 2007;12(3):232–50.PubMedCrossRefGoogle Scholar
  27. 27.
    Kagel JH, Battalio RC, Miles CG. Marihuana and work performance: results from an experiment. J Hum Resour. 1980;15(3):373–95.PubMedCrossRefGoogle Scholar
  28. 28.
    Phillips JA, Holland MG, Baldwin DD, Gifford-Meuleveld L, Mueller KL, Perkison B, et al. Marijuana in the workplace: guidance for occupational health professionals and employers: joint guidance statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine. Workplace Health Saf. 2015;63(4):139–64.PubMedCrossRefGoogle Scholar
  29. 29.
    The U.S. National Archives and Records Administration. Executive Order 12564--Drug-free Federal workplace [Internet]. National Archives. 2016 [cited .2017 Nov 15]. Available from:
  30. 30.
    Bush DM. The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int. 2008;174(2):111–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs [Internet]. Federal Register; 2017 [cited 2017 Nov 15]. Available from:
  32. 32.
    Wickizer TM, Kopjar B, Franklin G, Joesch J. Do drug-free workplace programs prevent occupational injuries? Evidence from Washington State. Health Serv Res. 2004;39(1):91–110.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Fortner NA, Martin DM, Esen SE, Shelton L. Employee drug testing: study shows improved productivity and attendance and decreased workers’ compensation and turnover. J Glob Drug Policy Pract. 2011;5:1–22.Google Scholar
  34. 34.
    Center for Behavioral Health Statistics and Quality. Results from the 2015 National Survey on Drug Use and Health: detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016.Google Scholar
  35. 35.
    Macdonald S, Hall W, Roman P, Stockwell T, Coghlan M, Nesvaag S. Testing for cannabis in the work-place: a review of the evidence. Addiction. 2010;105(3):408–16.PubMedCrossRefGoogle Scholar
  36. 36.
    Spell CS, Blum TC. Organizational adoption of preemployment drug testing. J Occup Health Psychol. 2001;6(2):114–26.PubMedCrossRefGoogle Scholar
  37. 37.
    Pidd K, Roche AM. How effective is drug testing as a workplace safety strategy? A systematic review of the evidence. Accid Anal Prev. 2014;71(Suppl C):154–65.PubMedCrossRefGoogle Scholar
  38. 38.
    Knudsen HK, Roman PM, Johnson JA. The management of workplace deviance: organizational responses to employee drug use. J Drug Issues. 2004;34(1):121–43.CrossRefGoogle Scholar
  39. 39.
    Sonnenstuhl WJ, Trice HM. Strategies for employee assistance programs: the crucial balance, vol. 102. Ithaca, NY: Cornell University Press; 1990.Google Scholar
  40. 40.
    Employee Assistance Society of North America. History and growth of the EAP field. EASNA Res Notes 2009;1(1).Google Scholar
  41. 41.
    What is EAP? [Internet]. [cited 2017 Nov 16]. Available from:
  42. 42.
    Delaney W, Grube JW, Ames GM. Predicting likelihood of seeking the employee assistance salaried and union hourly help through program among employees. Addiction. 1998;93(3):399–410.PubMedCrossRefGoogle Scholar
  43. 43.
    Selvik R, Stephenson D, Plaza C, Sugden B. EAP impact on work, relationship, and health outcomes. J Empl Assist. 2004;(2nd Quarter):18–22.Google Scholar
  44. 44.
    Waehrer GM, Miller TR, Hendrie D, Galvin DM. Employee assistance programs, drug testing, and workplace injury. J Saf Res. 2016;57(Suppl C):53–60.CrossRefGoogle Scholar
  45. 45.
    Blum TC, Roman PM. Cost-effectiveness and preventive implications of employee assistance programs [Internet]. Substance Abuse and Mental Health Services Admin; 1995 [cited 2017 Dec 6]. Available from:
  46. 46.
    Levy Merrick ES, Volpe-Vartanian J, Horgan CM, McCann B. Revisiting employee assistance programs and substance use problems in the workplace: key issues and a research agenda. Psychiatr Serv. 2007;58(10):1262–4.PubMedCentralCrossRefGoogle Scholar
  47. 47.
    CDC. Wellness at work [Internet]. Centers for Disease Control and Prevention; 2015 [cited 2017 Nov 20]. Available from:
  48. 48.
    Mattke S, Liu HH, Caloyeras J, Huang CY, Van Busum KR, Khodyakov D, et al. Workplace wellness programs study [Internet]. RAND Corporation; 2013 [cited 2017 Nov 29]. Available from:
  49. 49.
    Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002;325(7357):188.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Baldisseri MRM. Impaired healthcare professional. [Review]. Crit Care Med Organ Manag Ethics Intensive Care Unit. 2007;35(2)PubMedCrossRefGoogle Scholar
  51. 51.
    Hughes PH, Brandenburg N, Baldwin DC, Storr CL, Williams KM, Anthony JC, et al. Prevalence of substance use among US physicians. JAMA. 1992;267(17):2333–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Boyd JW, Knight JR. Ethical and managerial considerations regarding state physician health programs. J Addict Med. 2012;6(4):243–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Girotto E, Mesas AE, de Andrade SM, Birolim MM. Psychoactive substance use by truck drivers: a systematic review. Occup Environ Med. 2014;71(1):71–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Crouch DJ, Birky MM, Gust SW, Rollins DE, Walsh JM, Moulden JV, et al. The prevalence of drugs and alcohol in fatally injured truck drivers. J Forensic Sci. 1993;38(6):1342–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Commercial Vehicle Safety Alliance. CVSA releases 2017 International Roadcheck results [Internet]. CVSA - Commercial Vehicle Safety Alliance. [cited 2017 Dec 7]. Available from:
  56. 56.
    Commercial driver’s license drug and alcohol clearinghouse [Internet]. Federal Motor Carrier Safety Administration; 2016 [cited 2017 Dec 7]. Available from:
  57. 57.
    Li G, Brady JE, DiMaggio C, Baker SP, Rebok GW. Validity of suspected alcohol and drug violations in aviation employees. Addiction. 2010;105(10):1771–5.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    HIMS. Home [Internet]. [cited 2018 Jan 16]. Available from:
  59. 59.
    FADAP. FADAP Home [Internet]. [cited 2018 Jan 16]. Available from:
  60. 60.
    London chefs believe long hours culture is harming their health [Internet]. [cited 2018 Jan 11]. Available from:
  61. 61.
    The Arbor Behavioral Healthcare. Substance abuse in the restaurant and bar industry - The Arbor [Internet]. The Arbor Behavioral Healthcare; 2017 [cited 2018 Jan 11]. Available from:
  62. 62.
    Restaurant Recovery [Internet]. Restaurant Recovery. [cited 2018 Jan 12]. Available from:
  63. 63.
    The Heirloom Foundation [Internet]. The Heirloom Foundation. [cited 2018 Jan 12]. Available from:
  64. 64.
    Hospitality Action | Hospitality Action [Internet]. [cited 2018 Jan 11]. Available from:

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Justine W. Welsh
    • 1
  • Yujia Shentu
    • 1
  • J. Wesley Boyd
    • 2
    • 3
    Email author
  1. 1.Department of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlantaUSA
  2. 2.Department of PsychiatryCambridge Health Alliance and Harvard Medical SchoolBostonUSA
  3. 3.Center for BioethicsHarvard Medical SchoolBostonUSA

Personalised recommendations